NJSの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/04/19 | 2,018 | 2,042 | 2,015 | 2,027 | +9 | +0.4% | 3,800 |
2022/04/18 | 2,032 | 2,038 | 2,015 | 2,018 | -14 | -0.7% | 7,400 |
2022/04/15 | 2,018 | 2,039 | 2,018 | 2,032 | +2 | +0.1% | 3,300 |
2022/04/14 | 2,055 | 2,055 | 2,020 | 2,030 | +25 | +1.2% | 3,500 |
2022/04/13 | 2,011 | 2,018 | 2,005 | 2,005 | -15 | -0.7% | 6,000 |
2022/04/12 | 2,011 | 2,026 | 2,011 | 2,020 | ±0 | ±0% | 2,900 |
2022/04/11 | 2,029 | 2,045 | 2,006 | 2,020 | -20 | -1% | 6,800 |
2022/04/08 | 2,060 | 2,061 | 2,017 | 2,040 | -20 | -1% | 10,000 |
2022/04/07 | 2,036 | 2,066 | 2,036 | 2,060 | ±0 | ±0% | 5,200 |
2022/04/06 | 2,066 | 2,066 | 2,053 | 2,060 | ±0 | ±0% | 3,000 |
2022/04/05 | 2,048 | 2,068 | 2,046 | 2,060 | +19 | +0.9% | 5,300 |
2022/04/04 | 2,048 | 2,050 | 2,029 | 2,041 | +6 | +0.3% | 5,100 |
2022/04/01 | 2,021 | 2,044 | 2,021 | 2,035 | +19 | +0.9% | 3,800 |
2022/03/31 | 2,045 | 2,045 | 2,016 | 2,016 | -19 | -0.9% | 7,600 |
2022/03/30 | 2,036 | 2,042 | 2,013 | 2,035 | -1 | ±0% | 5,900 |
2022/03/29 | 2,025 | 2,036 | 2,014 | 2,036 | +11 | +0.5% | 9,100 |
2022/03/28 | 2,020 | 2,025 | 2,015 | 2,025 | +4 | +0.2% | 4,600 |
2022/03/25 | 2,020 | 2,021 | 2,006 | 2,021 | +1 | ±0% | 4,600 |
2022/03/24 | 2,007 | 2,020 | 2,001 | 2,020 | +13 | +0.6% | 4,800 |
2022/03/23 | 1,998 | 2,013 | 1,998 | 2,007 | +13 | +0.7% | 4,900 |
2022/03/22 | 1,977 | 1,994 | 1,971 | 1,994 | +17 | +0.9% | 3,300 |
2022/03/18 | 1,963 | 1,977 | 1,954 | 1,977 | +14 | +0.7% | 3,600 |
2022/03/17 | 1,965 | 1,965 | 1,939 | 1,963 | +14 | +0.7% | 6,300 |
2022/03/16 | 1,952 | 1,965 | 1,941 | 1,949 | +17 | +0.9% | 8,300 |
2022/03/15 | 1,912 | 1,935 | 1,912 | 1,932 | +8 | +0.4% | 2,800 |
2022/03/14 | 1,905 | 1,924 | 1,905 | 1,924 | +17 | +0.9% | 2,100 |
2022/03/11 | 1,892 | 1,922 | 1,892 | 1,907 | -5 | -0.3% | 3,300 |
2022/03/10 | 1,898 | 1,916 | 1,862 | 1,912 | +27 | +1.4% | 7,200 |
2022/03/09 | 1,914 | 1,928 | 1,813 | 1,885 | -1 | -0.1% | 17,300 |
2022/03/08 | 1,926 | 1,935 | 1,866 | 1,886 | -69 | -3.5% | 23,400 |
2022/03/07 | 2,008 | 2,017 | 1,955 | 1,955 | -57 | -2.8% | 16,900 |
2022/03/04 | 2,014 | 2,023 | 2,010 | 2,012 | -8 | -0.4% | 3,000 |
2022/03/03 | 2,020 | 2,027 | 2,013 | 2,020 | ±0 | ±0% | 2,400 |
2022/03/02 | 2,025 | 2,029 | 2,013 | 2,020 | -5 | -0.2% | 7,500 |
2022/03/01 | 2,014 | 2,027 | 2,011 | 2,025 | +13 | +0.6% | 4,000 |
2022/02/28 | 2,021 | 2,021 | 2,010 | 2,012 | -8 | -0.4% | 3,000 |
2022/02/25 | 2,020 | 2,020 | 2,011 | 2,020 | +16 | +0.8% | 6,100 |
2022/02/24 | 2,010 | 2,010 | 1,993 | 2,004 | -6 | -0.3% | 3,900 |
2022/02/22 | 2,003 | 2,015 | 1,999 | 2,010 | +1 | ±0% | 2,200 |
2022/02/21 | 1,998 | 2,011 | 1,998 | 2,009 | +8 | +0.4% | 3,400 |
2022/02/18 | 2,007 | 2,007 | 1,996 | 2,001 | +1 | +0.1% | 1,600 |
2022/02/17 | 1,991 | 2,007 | 1,991 | 2,000 | +9 | +0.5% | 1,400 |
2022/02/16 | 2,007 | 2,007 | 1,976 | 1,991 | +14 | +0.7% | 3,500 |
2022/02/15 | 1,994 | 2,017 | 1,975 | 1,977 | +8 | +0.4% | 14,600 |
2022/02/14 | 1,970 | 1,985 | 1,966 | 1,969 | -6 | -0.3% | 3,900 |
2022/02/10 | 1,974 | 1,989 | 1,970 | 1,975 | -9 | -0.5% | 5,300 |
2022/02/09 | 1,968 | 1,984 | 1,968 | 1,984 | +17 | +0.9% | 1,300 |
2022/02/08 | 1,971 | 1,984 | 1,967 | 1,967 | -3 | -0.2% | 3,600 |
2022/02/07 | 1,970 | 1,987 | 1,965 | 1,970 | -12 | -0.6% | 4,900 |
2022/02/04 | 1,968 | 1,990 | 1,968 | 1,982 | +17 | +0.9% | 3,200 |
601~
650
件表示中 / 5391件
類似銘柄と比較する
現在ご覧いただいている「NJS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NJS | 342,000円 | +2.2% | +73.1% | 2.78% | 15.50倍 | 1.22倍 |
|
上下水道のコンサルタント。官公需がほとんど。調査から設計・施工監理まで一貫。海外拠点多数 |
ワールドHD | 194,800円 | +17.9% | -15.9% | 4.15% | 7.36倍 | 0.86倍 |
|
製造派遣・請負が主力。技術者・研究者派遣や大都市で土地・マンション分譲も。配当性向3割 |
シーティーエス | 82,600円 | +8.2% | +5.9% | 3.03% | 17.50倍 | 2.83倍 |
|
建設ICTの専門会社。現場向けITインフラ、測量計測機器軸に全国展開。配当は業績に連動 |
WDB | 171,000円 | +5.1% | -13.4% | 3.54% | 11.31倍 | 1.12倍 |
|
理学系研究職や研究補助職の人材派遣で首位。医薬品開発受託(CRO)や医薬関連事務も |
アイロムG | 277,500円 | - | - | - | - | 2.63倍 |
|
SMO(医療機関向け治験支援)主力。日・豪でCRO(医薬品開発受託)。MBO実施準備 |
市場注目の銘柄
チャート関連のコラム